	Statistical cure, dynamic survivorship, and landmark-updated risk assessment in T-lymphoblastic lymphoma: A multicenter cohort study with population-based corroboration. Chin J Cancer Res Chai J, Sun Y, Lei X, Zhao L, Chen J, An N, Zhang W, Wang Y, Ping L, Song Y, Yu H. PMID: 43005383 [PubMed]
	Construction and validation of a differential diagnosis model for multiple myeloma and lymphoma based on XGBoost machine learning: an explaining analysis study of SHAP. BMC Med Inform Decis Mak Su J, Qi S, Peng T, Chen Z, Zhao Y, Liang P, Chen Z, Xia Z, Yang H. PMID: 43004305 [PubMed - indexed for MEDLINE]
	Dynamic prognostic stratification and survival prediction in elderly patients with diffuse large B-cell lymphoma: a real-world evidence study. BMC Cancer Jin Y, Zhou X, Chen X. PMID: 43004283 [PubMed - indexed for MEDLINE]
	Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma in Europe. Leuk Lymphoma Mitteldorf C, de Masson A, Beylot-Barry M, Gutierrez A, Muniesa C, Gonzalez Barca E, Dippel E, Wobser M, Zomas A, Stache V, Assaf C. PMID: 43004205 [PubMed - as supplied by publisher]
	Feasibility of Simulated Low-Dose CT with Deep Learning Denoising for Lymphoma PET/CT Imaging: A Clinical Study on Lesion Detection, Staging, and Therapy Response. J Imaging Inform Med He Y, Peng H, Li Z, Zou W, Xiang F, Li Y, Liu X, Dong Y, Chi D, Yang W, Liao M. PMID: 43004067 [PubMed - as supplied by publisher]
	Advances in CBFA2T3::GLIS2 fusion gene in pediatric acute myeloid leukemia: from molecular mechanisms to targeted therapeutic strategies. Ann Hematol She J, Guo L, Yang Y, Liu J, Zhang R, Liu Y, Guo H, Huang Y, Liu W. PMID: 43004022 [PubMed - indexed for MEDLINE]
	Infectious complications following bispecific antibody or CAR T therapy in adult patients with hematologic malignancies: a retrospective database analysis. Blood Cancer J Michael M, Mishriky F, Ouranos K, Hassan N, Mylona EK, Shehadeh F, Koutouratsas T, Avila D, Das S, Petkova J, Mylonakis E. PMID: 43003799 [PubMed - indexed for MEDLINE]
	Factors influencing discharge readiness in acute leukemia patients and implications for nursing care: a mixed-methods study. Rev Esc Enferm USP Tian X, Ma X, Liu W, Sun J, Gao G, Wang S. PMID: 43002656 [PubMed - indexed for MEDLINE]
	Lessons and limitations of the PARADIGM trial in acute myeloid leukemia. Clin Adv Hematol Oncol Kantarjian HM. PMID: 43002480 [PubMed - in process]
	Safety and feasibility of peripherally inserted central catheter (PICC) placement in patients with newly diagnosed acute leukemia: A single-center retrospective study. Ann Hematol Wei Y, Zhang X, Zhao F, He Y, Hu J. PMID: 43002293 [PubMed - indexed for MEDLINE]
	Efficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis. Daru Xu Y, Chen S, Zhang R. PMID: 43002273 [PubMed - indexed for MEDLINE]
	Steroid-Related Neuropsychiatric Symptoms (SRNS) in Children with Acute Lymphoblastic Leukemia (ALL): A Systematic Review of Clinical Features, Risk Factors, and Management. Cancer Manag Res Falana K, Ludwinek K, Siwko M, Sat, Paw, Zawitkowska J, Samardakiewicz M. PMID: 43001147 [PubMed]
	Individualizing Apheresis Processing Volumes Using a Predictive Algorithm: Analysis of the CAR T-Cell Collection Protocol Utilized in ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL. J Clin Apher Croden J, Breckenridge Z, Yin C, Debes-Marun C, Thapa B, Sandhu I, Chu MP. PMID: 43000203 [PubMed - indexed for MEDLINE]
	Life Expectancy in Hairy Cell Leukemia: An Updated SEER Study of 5669 Patients. J Blood Med Mustafa A. PMID: 42999862 [PubMed]
	Outcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors (BTKi): A Retrospective Study From a Tertiary Healthcare Center in North India. Cureus Shukla A, Pandey A, Verma SP, Sinha S, Tripathi A, Shukla N, Dutta G, Raghuveer P. PMID: 42999795 [PubMed]
	Patient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO. Clin Lymphoma Myeloma Leuk Gregory GP, Abramson JS, Huang H, Zhang Q, Ku M, Yoon DH, Fox CP, Abdulhaq H, Townsend W, Ashby J, Harris A, Mulvihill E, Kallemeijn M, Kesavan M, Ta R, Choeurng V, Lundberg L, Zhang H. PMID: 42998919 [PubMed - as supplied by publisher]
	SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics. Leuk Res Hu R, Gao L, Hong F, Li X, Liu Y, Yang Y. PMID: 42998614 [PubMed - as supplied by publisher]
	Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study. Leuk Res Veenstra A, Oortgiesen BE, Jansman FGA, van Gelder M, Levin MD, Veeger NJGM, Hoogendoorn M, HemoBase Population Registry Consortium. PMID: 42998613 [PubMed - as supplied by publisher]
	Real-world efficacy and safety of blinatumomab across three clinical settings in pediatric B-cell acute lymphoblastic leukemia: a single-center retrospective cohort study. Transl Cancer Res Gao S, Chen T, Qu L, Wang J, Tong W. PMID: 42997754 [PubMed]
	Investigation of selected MiRNA as potential biomarker in chronic myeloid leukemia patients. Med Pharm Rep Alqaraleh M, Alhmoud JF, Dababneh II, Odeh NL, Dala-Ali SN, Alhiary LS, Al-Rawashde FA. PMID: 42997673 [PubMed]

Articles 1 - 20 / 171287

Page 1 of 8565



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy